Trials / Completed
CompletedNCT01652885
Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis
An Open-Label Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of AN2728 Ointment in Adolescents With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety, tolerability, and systemic exposure of AN2728 Topical Ointment, 2%, in subjects with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AN2728 Topical Ointment, 2% | AN2728 Topical Ointment, 2% |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-10-01
- Completion
- 2012-11-01
- First posted
- 2012-07-30
- Last updated
- 2017-04-24
- Results posted
- 2017-04-24
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01652885. Inclusion in this directory is not an endorsement.